Literature DB >> 27029390

How to translate clinical trial results into gain in healthy life expectancy for individual patients.

Jannick A N Dorresteijn1, Lotte Kaasenbrood2, Nancy R Cook3, Rob C M van Kruijsdijk2, Yolanda van der Graaf4, Frank L J Visseren2, Paul M Ridker3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27029390     DOI： 10.1136/bmj.i1548

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  20 in total

1.  Prediction of individual life-years gained without cardiovascular events from lipid, blood pressure, glucose, and aspirin treatment based on data of more than 500 000 patients with Type 2 diabetes mellitus.

Authors:  Gijs F N Berkelmans; Soffia Gudbjörnsdottir; Frank L J Visseren; Sarah H Wild; Stefan Franzen; John Chalmers; Barry R Davis; Neil R Poulter; Annemieke M Spijkerman; Mark Woodward; Sara L Pressel; Ajay K Gupta; Yvonne T van der Schouw; Ann-Marie Svensson; Yolanda van der Graaf; Stephanie H Read; Bjorn Eliasson; Jannick A N Dorresteijn
Journal:  Eur Heart J       Date:  2019-09-07       Impact factor: 29.983

Review 2.  Personalized evidence based medicine: predictive approaches to heterogeneous treatment effects.

Authors:  David M Kent; Ewout Steyerberg; David van Klaveren
Journal:  BMJ       Date:  2018-12-10

3.  Estimated Stroke-Free Survival of Folic Acid Therapy for Hypertensive Adults: Projection Based on the CSPPT.

Authors:  Tiantian Zhang; Tengfei Lin; Yang Wang; Binyan Wang; Xianhui Qin; Feng Xie; Yimin Cui; Yong Huo; Xiaobin Wang; Zugui Zhang; Jie Jiang
Journal:  Hypertension       Date:  2019-12-23       Impact factor: 10.190

4.  Prediction of individualized lifetime benefit from cholesterol lowering, blood pressure lowering, antithrombotic therapy, and smoking cessation in apparently healthy people.

Authors:  Nicole E M Jaspers; Michael J Blaha; Kunihiro Matsushita; Yvonne T van der Schouw; Nicholas J Wareham; Kay-Tee Khaw; Marie H Geisel; Nils Lehmann; Raimund Erbel; Karl-Heinz Jöckel; Yolanda van der Graaf; W M Monique Verschuren; Jolanda M A Boer; Vijay Nambi; Frank L J Visseren; Jannick A N Dorresteijn
Journal:  Eur Heart J       Date:  2020-03-14       Impact factor: 35.855

5.  Cost-Effectiveness of Intensifying Lipid-Lowering Therapy With Statins Based on Individual Absolute Benefit in Coronary Artery Disease Patients.

Authors:  Manon C Stam-Slob; Yolanda van der Graaf; Jacoba P Greving; Jannick A N Dorresteijn; Frank L J Visseren
Journal:  J Am Heart Assoc       Date:  2017-02-18       Impact factor: 5.501

6.  Variation in minimum desired cardiovascular disease-free longevity benefit from statin and antihypertensive medications: a cross-sectional study of patient and primary care physician perspectives.

Authors:  Nicole E M Jaspers; Frank L J Visseren; Mattijs E Numans; Yvo M Smulders; Fere A van Loenen Martinet; Yolanda van der Graaf; Jannick A N Dorresteijn
Journal:  BMJ Open       Date:  2018-05-26       Impact factor: 2.692

7.  SCORE2-OP risk prediction algorithms: estimating incident cardiovascular event risk in older persons in four geographical risk regions.

Authors: 
Journal:  Eur Heart J       Date:  2021-07-01       Impact factor: 35.855

8.  Comparison and Implication of the Contemporary Blood Pressure Guidelines on Korean Population.

Authors:  So Mi Jemma Cho; Hokyou Lee; Hyeon Chang Kim
Journal:  Korean Circ J       Date:  2020-02-18       Impact factor: 3.243

Review 9.  Effects of Vegetable Proteins on Hypercholesterolemia and Gut Microbiota Modulation.

Authors:  Marco Busnelli; Stefano Manzini; Cesare R Sirtori; Giulia Chiesa; Cinzia Parolini
Journal:  Nutrients       Date:  2018-09-06       Impact factor: 5.717

10.  Estimated Life Expectancy Without Recurrent Cardiovascular Events in Patients With Vascular Disease: The SMART-REACH Model.

Authors:  Lotte Kaasenbrood; Deepak L Bhatt; Jannick A N Dorresteijn; Peter W F Wilson; Ralph B D'Agostino; Joseph M Massaro; Yolanda van der Graaf; Maarten J M Cramer; L Jaap Kappelle; Gert J de Borst; Ph Gabriel Steg; Frank L J Visseren
Journal:  J Am Heart Assoc       Date:  2018-08-21       Impact factor: 5.501
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.